More than 17,000 cancer researchers, health professionals and cancer survivors and advocates met at the 101st Annual Meeting of the American Association for Cancer Research 2010, from Saturday, April 17, to Wednesday, April 21, in Washington, D.C. This theme of the meeting, "Conquering Cancer Through Discovery Research," highlighted novel approaches and technologies being used in the laboratory, innovative preclinical science, clinical trial results and more. During the meeting the AACR interviewed many of the preeminent leaders in the global cancer community and share them with you on this page.
Friday, April 16, Podcasts and Teleconferences
Annual Meeting 2010 Episode 25: Interview with Frank McCormick, Ph.D., Program Committee Chairperson
Annual Meeting 2010 Episode 26: Interview with Lisa Paulsen, president and CEO of the Entertainment Industry Foundation, and co-founder of Stand Up To Cancer
Sunday, April 18 Videos, Podcasts and Teleconferences
"It's Our Time" video, a dynamic, five-minute video detailing the striking statistics of the progress and promise of cancer research. "It's Our Time" was first presented at the Opening Ceremony of the AACR 101st Annual Meeting 2010.
Annual Meeting 2010 Episode 27: Interview with Janet Rowley, M.D., D.Sc., the Blum-Riese distinguished service professor of medicine, molecular genetics and cell biology, and human genetics at the University of Chicago
Annual Meeting 2010 Episode 28: Listen to an interview with Laura Ziskin, co-founder of Stand Up To Cancer and movie producer, talk about her commitment to cancer research.
Teleconference: BATTLE Trial Confirms Efficacy of Personalized Medicine in Lung Cancer
Edward S. Kim, M.D., associate professor of thoracic and head and neck medical oncology at the University of Texas M. D. Anderson Cancer Center, and lead researcher on the BATTLE trial, and other researchers at M. D. Anderson discuss a novel Phase II clinical trial program, BATTLE (Biomarker-integrated Approaches of Targeted Therapy for Lung Cancer Elimination). Results suggest that patients prescribed treatment with existing drugs based on their tumor biomarkers benefit more than patients whose treatment is not based on their tumor biomarkers.
Teleconference: A Multi-Disciplinary Approach to Cancer Detection and Treatment: What’s On the Horizon
Laura J. van 't Veer, Ph.D., visiting associate professor in the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco, School of Medicine, hosts a press conference where selected abstracts of biology, technology and emerging therapies from more than 6,300 abstracts being presented at the annual meeting.
Annual Meeting 2010 Episode 29: Phillip A. Sharp, Ph.D., institute professor at the David H. Koch Institute for Integrative Cancer Research at MIT, and the recipient of the fourth annual AACR Margaret Foti Award, talks about the major discoveries of his career and the award.
Annual Meeting 2010 Episode 30: Listen to Sherry Lansing, founder and chair of the Sherry Lansing Foundation; co-founder of Stand Up To Cancer; and trustee of the AACR Foundation; discuss her inspiring work on behalf of cancer patients worldwide.
Monday, April 19 Podcasts and Teleconferences
Teleconference: MicroRNAs May be Key to Cancer Knowledge and Future Cures
Nobel Laureate Phillip A. Sharp, Ph.D., institute professor at the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology, Cambridge, hosts this press conference on recent research on microRNAs announced at this year’s annual meeting.
Teleconference: Breast Cancer Prevention: Raloxifene as Effective as Tamoxifen with Fewer Side Effects
Raloxifene improved its effectiveness against noninvasive breast cancer, caused significantly less endometrial cancer and was significantly less toxic than tamoxifen. Full results of the Study of Tamoxifen and Raloxifene (STAR) P-2 trial in breast cancer prevention are discussed in this press conference by a panel of experts.
Annual Meeting 2010 Episode 31: Recipients of the 2009 Nobel Prize in Physiology or Medicine, Elizabeth H. Blackburn, Ph.D., and Carol Greider, Ph.D., talk about their discovery of how chromosomes are protected by telomeres and the enzyme telomerase and the honor of receiving the Nobel Prize.
Annual Meeting 2010 Episode 32: Larry Wickerham, M.D., lead researcher of the STAR P-2 Trial and associate chairman of the National Surgical Adjuvant Breast and Bowel Project, discusses results of the follow-up Study of Tamoxifen and Raloxifene.
How Infection and Inflammation Can Lead to Cancer
William G. Nelson V, M.D., Ph.D., professor and director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, led a panel of researchers in a press conference about new research on infection, inflammation and cancer that suggests a link between infection-related diseases and risk of cancer.
Annual Meeting 2010 Episode 33: Julie M. Fleshman, J.D., M.B.A., president and chief executive officer of the Pancreatic Cancer Action Network, and recipient of AACR’s Distinguished Public Service Award, talks about her commitment to changing the course of pancreatic cancer.
Annual Meeting 2010 Episode 34: Listen to Louis M. Weiner, M.D., director of the Georgetown Lombardi Comprehensive Cancer Center, talk about recent developments in immunotherapy and his vision as chair of the AACR Cancer Immunology Working Group.
Tuesday, April 20 Podcasts and Teleconferences
Teleconference: Cancer Prevention Strategies Highlighted at AACR 101st Annual Meeting 2010
Ernest T. Hawk, M.D., M.P.H., vice president of the division of cancer prevention and population sciences at The University of Texas M. D. Anderson Cancer Center, leads a panel of scientists in a discussion of new information about cancer.
Annual Meeting 2010 Episode 35: Waun Ki Hong, M.D., division head and professor at the University of Texas M. D. Anderson Cancer Center, talks about his participation as a researcher on the BATTLE trial, a groundbreaking lung cancer biomarkers study.
Annual Meeting 2010 Episode 36: Recipient of the AACR’s Distinguished Public Service Award, John E. Niederhuber, M.D., director of the National Cancer Institute, talks about the honor of receiving this award, his accomplishments as head of the NCI since 2006, and his thoughts on the future of cancer research.
Annual Meeting 2010 Episode 37:
Joe W. Gray, Ph.D., director of the division of life sciences and associate laboratory director for life and environmental sciences at the Lawrence Berkeley National Laboratory, discusses the work of his Stand Up To Cancer Dream Team, “An Integrated Approach to Targeting Breast Cancer, Molecular Subtypes and their Resistance Phenotypes.”Annual Meeting 2010 Episode 38:
Judy E. Garber, M.D., M.P.H., AACR president-elect and the director of the Cancer Risk and Prevention Program at Dana-Farber Cancer Institute talks about her goals for her upcoming presidency and the future of cancer research.Annual Meeting 2010 Episode 39:
Listen to part 1 of Bayard D. Clarkson, M.D., AACR president from 1980 to 1981, Enid A. Haupt chair of therapeutic research at the Memorial Sloan-Kettering Cancer Center, talking about his career and recent resignation as AACR Treasurer, after serving in this role for an unprecedented five terms.
Annual Meeting 2010 Episode 40: Listen to part 2 of Bayard D. Clarkson, M.D., AACR president from 1980 to 1981, Enid A. Haupt chair of therapeutic research at the Memorial Sloan-Kettering Cancer Center, talking about his career and recent resignation as AACR Treasurer, after serving in this role for an unprecedented five terms.
Check back frequently to stay up-to-date or subscribe to the AACR Scientific Podcasts feed through the following:
Subscribe to the AACR Scientific Podcasts via an RSS Reader.
Follow AACR on Twitter @AACR and throughout the meeting using the hash tag #AACR10.
Subscribe to the AACR RSS News Feed
Updated: April 21, 2010